Strong Growth Ahead: Influenza Vaccines Market Size To Grow At Arecord 8.7% Cagr By 2029

The Influenza Vaccines Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

How Big Is the Influenza Vaccines Market Size Expected to Be by 2034?
In the past few years, the influenza vaccines market has experienced substantial growth. Its expansion is predicted to increase from a $7.35 billion market share in 2024 to a $7.9 billion value in 2025, growing at a compound annual growth rate (CAGR) of 7.5%. Factors contributing to this growth during the historic period include preparedness for pandemics, public health campaigns, effectiveness studies of vaccines, recommendations from healthcare professionals, and worldwide influenza monitoring.

The market size for influenza vaccines is predicted to witness significant expansion in the forthcoming years, escalating to $11.02 billion in 2029 at a Compound Annual Growth Rate (CAGR) of 8.7%. This growth during the projected period is credited to various factors such as changes in climate and environment, advances in healthcare accessibility, the emergence of novel influenza strains, advancements in adjuvants and delivery systems, and increased healthcare spending. The forthcoming period is expected to observe significant trends like broader application of mRNA vaccine technology, an emphasis on pediatric immunization, measures for seasonal influenza control, improved vaccination coverage in emerging economies, and personalized vaccination strategies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11935

What Are the Emerging Segments Within the Influenza Vaccines Market?
The influenza vaccines market covered in this report is segmented -

1) By Vaccine Type: Inactivated, Live Attenuated
2) By Valency: Quadrivalent, Trivalent
3) By Route Of Administration: Injection, Nasal Spray
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:
1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)
2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

What Long-Term Drivers Are Shaping Influenza Vaccines Market Trends?
The increasing occurrences of seasonal flu are projected to stimulate the expansion of the influenza vaccine industry. Seasonal flu is a respiratory disease triggered by flu viruses that commonly spread and cause infections during specific periods of the year, predominantly in colder climates. This alteration has stemmed from antigenic drift, susceptibility of the population, environmental influences, insufficient vaccine protection, and the absence of widespread immunization. Influenza vaccines aid in lessening the occurrences of seasonal flu by providing immunity against the prevalent strains of the virus. For instance, in November 2023, the Centers for Disease Control and Prevention (CDC), a government organization based in the United States, noted that there were roughly 31 million flu-associated illnesses, 14 million flu-related medical consultations, 360,000 hospitalizations due to flu, and 21,000 deaths related to the flu during the 2022-2023 flu season. Consequently, the escalating occurrences of flu seasons are fueling the advancement of the influenza vaccine industry.

Who Are the Top Competitors in Key Influenza Vaccines Market Segments?
Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

What Influenza Vaccines Market Trends Are Gaining Traction Across Different Segments?
The increasing adoption of cutting-edge vaccine production technology is a significant trend emerging in the influenza vaccine market. Firms in the influenza vaccine sector are leveraging state-of-the-art vaccine production technologies to maintain their market standing. An example of this is GlaxoSmithKline PLC., a British pharmaceutical and biotech company, which launched a Multiple Antigen Presenting System (MAPS) for vaccine development in January 2023. This innovative technology aids in the creation of effective vaccines against bacteria and viruses. Notably, it enables rapid vaccine development during an epidemic or pandemic outbreak.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Which Regions Are Becoming Hubs for Influenza Vaccines Market Innovation?
North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Influenza Vaccines Market?
2. What is the CAGR expected in the Influenza Vaccines Market?
3. What Are the Key Innovations Transforming the Influenza Vaccines Industry?
4. Which Region Is Leading the Influenza Vaccines Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.